Literature DB >> 8194566

Is partial deletion of the complement C4 genes associated with sudden infant death?

S H Opdal1, A Vege, O D Saugstad, T O Rognum.   

Abstract

The two C4 loci C4A and C4B in 61 cases of sudden infant death (SID), 93 living controls and 7 cases of infectious death were studied. In the SID group 13.1% showed deletion of the C4A gene, while 2.5% of the cases showed deletion of the C4B gene. This was not significantly different from neither the controls nor the infectious death group. We were not able to confirm that deletion of the C4B gene is associated with SID. However, in the SID group deletion of either the C4A or the C4B gene was associated with signs of infections prior to death (P = 0.035). This observation may indicate that a proportion of SID victims are more vulnerable to infections than other infants.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8194566     DOI: 10.1007/bf01954522

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  15 in total

1.  Development of intestinal mucosal immunity in fetal life and the first postnatal months.

Authors:  T O Rognum; S Thrane; L Stoltenberg; A Vege; P Brandtzaeg
Journal:  Pediatr Res       Date:  1992-08       Impact factor: 3.756

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Sudden infant death syndrome victims show local immunoglobulin M response in tracheal wall and immunoglobulin A response in duodenal mucosa.

Authors:  L Stoltenberg; O D Saugstad; T O Rognum
Journal:  Pediatr Res       Date:  1992-04       Impact factor: 3.756

4.  Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.

Authors:  L M Kunkel; K D Smith; S H Boyer; D S Borgaonkar; S S Wachtel; O J Miller; W R Breg; H W Jones; J M Rary
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

5.  Two HLA-linked loci controlling the fourth component of human complement.

Authors:  G J O'Neill; S Y Yang; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

6.  Covalent binding properties of the C4A and C4B isotypes of the fourth component of human complement on several C1-bearing cell surfaces.

Authors:  D E Isenman; J R Young
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

7.  Development of immune response markers in the trachea in the fetal period and the first year of life.

Authors:  L Stoltenberg; P S Thrane; T O Rognum
Journal:  Pediatr Allergy Immunol       Date:  1993-02       Impact factor: 6.377

8.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

9.  Possible association of sudden infant death with partial complement C4 deficiency revealed by post-mortem DNA typing of HLA class II and III genes.

Authors:  P M Schneider; C Wendler; T Riepert; L Braun; U Schacker; M Horn; H Althoff; R Mattern; C Rittner
Journal:  Eur J Pediatr       Date:  1989-12       Impact factor: 3.183

10.  Lung immunoglobulins in the sudden infant death syndrome.

Authors:  K D Forsyth; S C Weeks; L Koh; J Skinner; J Bradley
Journal:  BMJ       Date:  1989-01-07
View more
  2 in total

1.  Sudden infant death syndrome: exposure to cigarette smoke leads to hypomethylation upstream of the growth factor independent 1 (GFI1) gene promoter.

Authors:  Kristina Schwender; Hannah Holtkötter; Kristina Schulze Johann; Alina Glaub; Marianne Schürenkamp; Ulla Sibbing; Sabrina Banken; Mechtild Vennemann; Heidi Pfeiffer; Marielle Vennemann
Journal:  Forensic Sci Med Pathol       Date:  2016-09-27       Impact factor: 2.007

2.  Genomic risk factors in sudden infant death syndrome.

Authors:  David W Van Norstrand; Michael J Ackerman
Journal:  Genome Med       Date:  2010-11-30       Impact factor: 11.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.